Literature DB >> 17140708

Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.

George Mutwiri1, Ponn Benjamin, Henry Soita, Hugh Townsend, Richard Yost, Bryan Roberts, Alexander K Andrianov, Lorne A Babiuk.   

Abstract

We investigated the ability of a novel polyphosphazene polyelectrolyte, poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) to enhance antigen-specific immune responses. BALB/c mice were immunized once subcutaneously with either bovine serum albumin (BSA) or influenza virus X:31 antigen alone, or in combination with PCEP, or either of the adjuvants poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) and alum. Both PCEP and PCPP significantly enhanced serum antigen-specific total IgG, IgG1 and IgG2a antibody titers, and these responses were highest in PCEP-immunized mice. Alum induced only a modest enhancement of antibody responses. Reducing the dose of X:31 antigen by 25-fold had no effect on antibody responses in mice immunized with PCPP and PCEP, but resulted in reduced titers in those immunized with alum. Analysis of X:31 antigen-specific cytokines revealed that alum and PCPP were associated with a predominantly IL-4 response. In contrast, PCEP was associated with production of both IFNgamma and IL-4. We conclude that PCEP is a potent enhancer of antigen-specific Th1 and Th2 immune responses and is a promising adjuvant for vaccine applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140708     DOI: 10.1016/j.vaccine.2006.10.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Dorota Klaczkowska; Malin Hultqvist; Kristin Hagenow; Rikard Holmdahl; Kutty Selva Nandakumar
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

2.  Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.

Authors:  Alexander K Andrianov; Daniel P DeCollibus; Helice A Gillis; Henry H Kha; Alexander Marin; Mark R Prausnitz; Lorne A Babiuk; Hugh Townsend; George Mutwiri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

3.  Adjuvant properties of a biocompatible thermo-responsive polymer of N-isopropylacrylamide in autoimmunity and arthritis.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2011-05-04       Impact factor: 4.118

4.  Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies.

Authors:  John W Mapletoft; Laura Latimer; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

Review 5.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

6.  Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.

Authors:  Helena Henke; Kushtrim Kryeziu; Jelena Banfić; Sarah Theiner; Wilfried Körner; Oliver Brüggemann; Walter Berger; Bernhard K Keppler; Petra Heffeter; Ian Teasdale
Journal:  Macromol Biosci       Date:  2016-05-12       Impact factor: 4.979

7.  Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP.

Authors:  Sarah M Valencia; Athina Zacharia; Alexander Marin; Rebecca L Matthews; Chia-Kuei Wu; Breana Myers; Chelsea Sanders; Simone Difilippantonio; Reinhard Kirnbauer; Richard B Roden; Ligia A Pinto; Robert H Shoemaker; Alexander K Andrianov; Jason D Marshall
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

Review 8.  Polyphosphazene immunoadjuvants: Historical perspective and recent advances.

Authors:  Alexander K Andrianov; Robert Langer
Journal:  J Control Release       Date:  2020-12-05       Impact factor: 9.776

9.  Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.

Authors:  Alexander Marin; Ananda Chowdhury; Sarah M Valencia; Athina Zacharia; Reinhard Kirnbauer; Richard B S Roden; Ligia A Pinto; Robert H Shoemaker; Jason D Marshall; Alexander K Andrianov
Journal:  Nanomedicine       Date:  2021-01-18       Impact factor: 5.307

10.  In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly.

Authors:  Alexander K Andrianov; Alexander Marin; Ruixue Wang; Ananda Chowdhury; Pragati Agnihotri; Abdul S Yunus; Brian G Pierce; Roy A Mariuzza; Thomas R Fuerst
Journal:  Mol Pharm       Date:  2020-06-23       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.